Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bonlac (Beijing) Biotechnology is a specialized life sciences company focused on the research, development, and industrialization of probiotics and functional nutritional ingredients. The company maintains an extensive library of microbial strains and utilizes a proprietary platform for high-throughput screening and functional characterization. Their product portfolio targets key health areas including gastrointestinal wellness, immune system modulation, and metabolic health. Bonlac provides integrated services ranging from strain isolation and clinical efficacy trials to large-scale, high-density fermentation and stabilization. By collaborating with academic institutions and healthcare partners, the company aims to deliver evidence-based microbial solutions for the pharmaceutical, dietary supplement, and functional food sectors. Their operations are supported by advanced manufacturing facilities that adhere to international quality standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bonlac.